These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 35609823

  • 1. Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease.
    Steensig K, Pareek M, Krarup AL, Sogaard P, Maeng M, Tayal B, Lee CJ, Torp-Pedersen C, Lip GY, Holland-Fischer P, Kragholm KH.
    Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101952. PubMed ID: 35609823
    [Abstract] [Full Text] [Related]

  • 2. CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer.
    D'Souza M, Carlson N, Fosbøl E, Lamberts M, Smedegaard L, Nielsen D, Torp-Pedersen C, Gislason G, Schou M.
    Eur J Prev Cardiol; 2018 Apr; 25(6):651-658. PubMed ID: 29482441
    [Abstract] [Full Text] [Related]

  • 3. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH, Jensen M, Melgaard L, Skjøth F, Nielsen PB, Larsen TB.
    Europace; 2019 Jan 01; 21(1):33-40. PubMed ID: 29986001
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA2DS2-VASc Score 1: A Nationwide Study.
    Østergaard L, Olesen JB, Petersen JK, Nielsen LS, Kristensen SL, Schou M, Køber L, Fosbøl E.
    Circulation; 2024 Mar 05; 149(10):764-773. PubMed ID: 38152890
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S, Todo K, Koga M, Furui E, Kinoshita N, Kimura K, Yamagami H, Terasaki T, Yoshimura S, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Nagakane Y, Kameda T, Hasegawa Y, Shibuya S, Ito Y, Nakashima T, Takamatsu K, Nishiyama K, Matsuki T, Homma K, Takasugi J, Tokunaga K, Sato S, Kario K, Kitazono T, Toyoda K, SAMURAI Study Investigators.
    Int J Stroke; 2016 Jul 05; 11(5):565-74. PubMed ID: 26927811
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation based on a CHA2DS2-VASc score.
    Methavigul K, Chichareon P, Yindeengam A, Krittayaphong R.
    BMC Cardiovasc Disord; 2023 Dec 19; 23(1):623. PubMed ID: 38114960
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.
    Staerk L, Fosbøl EL, Lip GYH, Lamberts M, Bonde AN, Torp-Pedersen C, Ozenne B, Gerds TA, Gislason GH, Olesen JB.
    Eur Heart J; 2017 Mar 21; 38(12):907-915. PubMed ID: 27742807
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT, Liao JN, Chiang CE, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chao TF, Lip GYH, Chen SA.
    JAMA Netw Open; 2020 Jun 01; 3(6):e206424. PubMed ID: 32478848
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
    Anjum M, Ariansen I, Hjellvik V, Selmer R, Kjerpeseth LJ, Skovlund E, Myrstad M, Ellekjær H, Christophersen IE, Tveit A, Berge T.
    Eur Heart J; 2024 Jan 01; 45(1):57-66. PubMed ID: 37995254
    [Abstract] [Full Text] [Related]

  • 20. CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.
    Kim TH, Yang PS, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B, Lip GYH.
    Stroke; 2017 Jun 01; 48(6):1524-1530. PubMed ID: 28455320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.